Compound 451238
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Compound 451238, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma [Phase 1, Phase 2]